CannPal Studying Effects of THC and CBD on Dogs

Animal health firm CannPal Animal Therapeutics Limited (ASX: CP1) is testing the company's lead drug candidate CPAT-01 for pain and inflammation control in dogs. The...

Market Exclusive Biotech News & Analysis

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

Insys Therapeutics Inc. (NASDAQ:INSY) has been in an upward trend since the beginning of the month and in the last trading session, the stock...

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

Veritas Pharma Inc.’s (OTCMKTS:VRTHF) subsidiary Veritas Pharma Puerto Rico LLC has announced that they have successfully enrolled and dosed the first health adult volunteer...

Popular Posts

/* */
// AST – IMS - [MarketExclusive_ROS]